Clarivate

MAY 31, 2023

A glance at the 2022 top selling drugs for the biggest pharma companies reveals how dependent many large pharmas are on a small basket of products – most acquired through partnerships or acquisitions – that are nearing loss of exclusivity. billion in revenue to a whopping 67.2% of AbbVie’s $51.8 of AbbVie’s $51.8

Pharma 52

Pharma Biopharma Medicine Competition 52

Pharmaceutical Technology

FEBRUARY 8, 2023

The top 20 companies in the global biopharma industry saw 5.4%* aggregate market capitalization from $3.43 trillion over the past year, according to GlobalData’s Pharma Intelligence Center Companies Database. Johnson & Johnson maintained its top position in 2022, followed by Lilly. trillion to $3.61

Marketing 78

Marketing Biopharma Sales Pharma 78

Pharmaceutical Technology

MAY 16, 2023

More than half of the top 20 global biopharmaceutical companies saw a fall in market capitalisation over Q1 2023. trillion in Q1 2023, according to GlobalData’s pharma intelligence centre companies database. This resulted in a 3.4% decline in total aggregate market capitalisation from $3.61

Marketing 52

Marketing Sales Pharma Leads 52

Pharma Marketing Network

DECEMBER 17, 2021

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. HCP Engagement and Pharma Salesforces.

Pharma 105

Pharma Marketing Engineering Digital Media 105

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. In January 2023, VillageMD acquired Summit Health for $8.9

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

MAY 8, 2024

A glance at the 2023 and early 2024 life science dealmaking environment shows fewer, but higher-value, transactions. As companies face the prospect of major revenue challenges over the next few years, securing inorganic growth through strategic alliances is increasingly attractive.

Pharma 59

Pharma Biopharma Prospecting Competition 59

PM360

JULY 13, 2023

PM360 asked for companies to send in their latest and best ways to improve adherence. Here are twelve of the best examples of programs, strategies, solutions, technology, and more that companies have developed or are using to keep patients on their prescribed therapies. 1 About half of the general U.S.

Education 89

Education Medical Media Patients 89